The pharmaceutical industry is poised for a dynamic year in 2025. A confluence of positive trends suggests a brighter outlook ...

What makes these developments particularly exciting is what’s driving it. New report predicts pharmaceutical market to soar ...

IST, the barometer index, the S&P BSE Sensex, shed 172.42 points or 0.23% to 76,348.14. The Nifty 50 index lost 69.15 points or 0.30% to 23,136.20.

Ascentage Pharma said on Tuesday it was targeting a valuation of $1.75 billion in its initial public offering, becoming the ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid addiction ...

The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug ...

The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...

Strides Pharma share price has fallen over 10% in one month and 16% in three months. However, Strides Pharma stock has ...

The London Stock Exchange is set to lose another listing after Alliance Pharma agreed to be acquired in an all-cash deal that ...

Leo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure ...

Mankind Pharma shed 2.76% to Rs 2,560.05 after the company's consolidated net profit declined 16.2% to Rs 380.23 crore in Q3 FY25 as against Rs 453.76 crore posted in Q3 FY24.

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid addiction ...